Vandria is a biotechnology company investigating the potential of mitochondrial therapeutics to combat age-related and chronic diseases.

XPRIZE Healthspan is a $111M prize competition aiming to incentivize the development of therapeutics that significantly extend healthspan.

Metformin is used for type 2 diabetes treatment, however, it has recently gained significant attention in the field of anti-aging.

This summary highlights what we currently know of telomeres and the telomerase enzyme as potential anti-aging targets.

Rapamycin is used as an immunosuppressant, however, it has recently gained significant attention in the anti-aging research communities.

A recent study explores the potential of reversing age-related biological changes by targeting the insulin/IGF-1 signaling pathway

MetaShape Pharma is focused on developing therapies that address age-related diseases by restoring NAD+ levels in the body.

A recent study has shown that partial reprogramming of brain cells using Yamanaka factors can protect against neurodegeneration in mice.

A recently published research review explores ferroptosis and its significant implications for aging and age-related diseases.

Research suggests that an Astragalus-based supplement may help lengthen telomeres, and thereby reduce cellular age-related decline.